v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenues $ 2,554 $ 1,534 $ 5,434 $ 4,387
Cost of Revenues 645 382 1,459 1,109
Gross Profit 1,909 1,152 3,975 3,278
Operating Expenses        
Research and development 1,717 926 4,329 2,677
Sales and marketing 1,703 847 3,862 2,161
General and administrative 4,103 3,521 10,371 9,890
Acquisition related costs 344 573 540 1,220
Amortization of intangibles 288 969 1,811 2,602
Total Operating Expenses 8,155 6,836 20,913 18,550
Loss from Operations (6,246) (5,684) (16,938) (15,272)
Other Income (Expense)        
Interest expense, net (537) (1,190) (1,934) (2,053)
Provision for valuation allowance on held for sale loan (679) (1,514)
Loss on exchange of debt for equity (27) (132) (188)
Other income (expense) 11 289 (488) 518
Total Other Income (Expense) (1,205) (928) (4,068) (1,723)
Net Loss from Operations, before tax (7,451) (6,612) (21,006) (16,995)
Income tax benefit 33 87 35
Net Loss (7,451) (6,579) (20,919) (16,960)
Net Income Attributable to Non-controlling Interest 16 5 25 9
Net Loss Attributable to Stockholders of Inpixon (7,467) (6,584) (20,944) (16,969)
Deemed dividend for triggering of warrant down round feature (1,250)
Net Loss Attributable to Common Stockholders $ (7,467) $ (6,584) $ (20,944) $ (18,219)
Net Loss Per Share - Basic and Diluted $ (0.18) $ (12.68) $ (0.9) $ (65.89)
Weighted Average Shares Outstanding        
Basic and Diluted 41,544,961 519,257 23,203,004 276,499

Source